tiprankstipranks
Trending News
More News >
Sonnet BioTherapeutics Holdings (SONN)
NASDAQ:SONN
US Market

Sonnet BioTherapeutics Holdings (SONN) Revenue

Compare
517 Followers

Sonnet BioTherapeutics Holdings Revenue

Sonnet BioTherapeutics Holdings had a revenue of 0.00 in the quarter ending Mar 31, 2025, with -100.00%. This bring the company's revenue in the last twelve months to 1.00M, Decreased 0.00%. In the fiscal year ending Sep 30, 2024, Sonnet BioTherapeutics Holdings had annual revenue of 18.63K with -87.40% growth.
Revenue (ttm)
1.00M
Revenue Growth
978.39%
P/S Ratio
192.06
Revenue/Employee
$1,433
Employees
13
Market Cap
$3.58M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Sep 30, 2024
18.63K-129.18K-87.40%
Sep 30, 2023
147.81K-202.14K-57.76%
Sep 30, 2022
349.94K-133.68K-27.64%
Sep 30, 2021
483.63K+∞%
Sep 30, 2020
0.00-40.61M-100.00%
Sep 30, 2019
40.61M9.88M+32.15%
Dec 31, 2018
30.73M-10.70M-25.82%
Dec 31, 2017
41.43M-269.14K-0.65%
Dec 31, 2016
41.70M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis